Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Venous Thromboembolism | 5 | 2019 | 4273 | 0.70 | Why? |
| Heparin, Low-Molecular-Weight | 5 | 2021 | 1731 | 0.70 | Why? |
| Anticoagulants | 8 | 2021 | 9563 | 0.69 | Why? |
| Pregnancy Complications, Hematologic | 1 | 2019 | 114 | 0.68 | Why? |
| Vitamin K | 1 | 2019 | 263 | 0.63 | Why? |
| Thyroid Nodule | 1 | 2017 | 70 | 0.62 | Why? |
| Reproductive Techniques, Assisted | 2 | 2018 | 400 | 0.62 | Why? |
| Biopsy, Fine-Needle | 1 | 2017 | 274 | 0.61 | Why? |
| Blood Component Transfusion | 1 | 2020 | 740 | 0.56 | Why? |
| ADAMTS13 Protein | 1 | 2018 | 363 | 0.56 | Why? |
| Thrombotic Microangiopathies | 1 | 2018 | 335 | 0.55 | Why? |
| Blood Banks | 1 | 2020 | 535 | 0.53 | Why? |
| Anemia | 1 | 2019 | 789 | 0.46 | Why? |
| Blood Transfusion | 1 | 2021 | 1399 | 0.44 | Why? |
| Hip Fractures | 1 | 2019 | 667 | 0.43 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.35 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.31 | Why? |
| Thrombocytopenia | 1 | 2019 | 2093 | 0.30 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.21 | Why? |
| Factor XI Deficiency | 1 | 2019 | 7 | 0.21 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.19 | Why? |
| Receptor, Melatonin, MT2 | 1 | 2017 | 6 | 0.18 | Why? |
| Registries | 1 | 2018 | 12327 | 0.18 | Why? |
| Insulin Receptor Substrate Proteins | 1 | 2017 | 13 | 0.18 | Why? |
| Ovulation Induction | 1 | 2018 | 58 | 0.18 | Why? |
| Social Control, Formal | 1 | 2020 | 165 | 0.18 | Why? |
| Tetrahydrofolate Dehydrogenase | 1 | 1997 | 12 | 0.18 | Why? |
| Factor V | 1 | 1997 | 52 | 0.17 | Why? |
| Pregnancy Complications, Cardiovascular | 2 | 2017 | 231 | 0.17 | Why? |
| Postpartum Hemorrhage | 1 | 2018 | 144 | 0.16 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.15 | Why? |
| Pregnancy | 7 | 2019 | 23879 | 0.15 | Why? |
| Erythrocyte Transfusion | 1 | 2019 | 386 | 0.15 | Why? |
| Lupus Coagulation Inhibitor | 1 | 2018 | 262 | 0.14 | Why? |
| Plasma Exchange | 2 | 2019 | 763 | 0.14 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.14 | Why? |
| Administration, Oral | 2 | 2019 | 2340 | 0.14 | Why? |
| Purpura, Thrombotic Thrombocytopenic | 1 | 2018 | 284 | 0.13 | Why? |
| Thrombosis | 4 | 2020 | 7504 | 0.13 | Why? |
| Italy | 6 | 2021 | 38444 | 0.13 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.13 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.11 | Why? |
| Antiphospholipid Syndrome | 1 | 2018 | 533 | 0.11 | Why? |
| Blood Coagulation | 2 | 2021 | 2768 | 0.11 | Why? |
| Pre-Eclampsia | 1 | 1997 | 599 | 0.11 | Why? |
| Splanchnic Circulation | 1 | 2009 | 37 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 1997 | 1074 | 0.10 | Why? |
| Pregnancy Outcome | 2 | 2019 | 3803 | 0.09 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.09 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.09 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.09 | Why? |
| Heparin | 1 | 2021 | 2600 | 0.09 | Why? |
| Janus Kinase 2 | 1 | 2009 | 218 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.08 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.08 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.08 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.08 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.08 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.07 | Why? |
| Humans | 20 | 2021 | 930598 | 0.07 | Why? |
| Female | 12 | 2021 | 380317 | 0.06 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.06 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Aged | 7 | 2021 | 215776 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2019 | 6537 | 0.06 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Adult | 7 | 2019 | 244371 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.05 | Why? |
| Thromboplastin | 1 | 2021 | 275 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Live Birth | 1 | 2018 | 200 | 0.04 | Why? |
| Birth Rate | 1 | 2018 | 137 | 0.04 | Why? |
| Antibodies, Anticardiolipin | 1 | 2018 | 208 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Risk | 2 | 2018 | 5288 | 0.04 | Why? |
| Erythrocytes | 1 | 2021 | 617 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Mutation | 2 | 2009 | 12376 | 0.03 | Why? |
| Venous Thrombosis | 1 | 2009 | 2739 | 0.03 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.03 | Why? |
| Antibodies, Antiphospholipid | 1 | 2018 | 519 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Steroids | 1 | 2018 | 904 | 0.03 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.03 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.03 | Why? |
| Circadian Rhythm | 1 | 2017 | 607 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Endothelial Cells | 1 | 2021 | 2048 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.03 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Genetic Predisposition to Disease | 2 | 2009 | 4027 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.02 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Fibrinolytic Agents | 1 | 2019 | 1702 | 0.02 | Why? |
| Viruses | 1 | 2021 | 2238 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Pregnancy Complications | 1 | 2018 | 1388 | 0.02 | Why? |
| Chi-Square Distribution | 1 | 2009 | 961 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2018 | 2705 | 0.02 | Why? |
| Gene Frequency | 1 | 2009 | 1210 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.01 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.01 | Why? |
| Phenotype | 1 | 2009 | 4037 | 0.01 | Why? |
| Case-Control Studies | 1 | 1997 | 17671 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2018 | 12447 | 0.01 | Why? |
| Adolescent | 2 | 2009 | 86841 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
Grandone's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(187)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_